Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TRxADE HEALTH Inc.

    NASDAQ: MEDS · Real-Time Price · USD
    7.59
    0.33 (4.55%)
    At close: Sep 20, 2024, 10:00 PM
    7.59
    0.00%
    After-hours: Sep 20, 2024, 04:00 PM EDT

    TRxADE HEALTH Statistics

    Share Statistics

    TRxADE HEALTH has 1.75M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 1.75M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.05%

    Shares Floating

    n/a
    		 734.54K

    Failed to Deliver (FTD) Shares

    n/a
    		 1,351

    FTD / Avg. Volume

    n/a
    		 2.19%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.22 and the forward PE ratio is null. TRxADE HEALTH's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.22

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.48

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 7.33

    P/FCF Ratio

    n/a
    		 -1.92

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    TRxADE HEALTH has an Enterprise Value (EV) of 10.93M.

    EV / Sales

    n/a
    		 1.32

    EV / EBITDA

    n/a
    		 -0.8

    EV / EBIT

    n/a
    		 -5.27

    EV / FCF

    n/a
    		 -5.27

    Financial Position

    The company has a current ratio of 0.24, with a Debt / Equity ratio of 13.1.

    Current Ratio

    n/a
    		 0.24

    Quick Ratio

    n/a
    		 0.24

    Debt / Equity

    n/a
    		 13.1

    Debt / EBITDA

    n/a
    		 -0.52

    Debt / FCF

    n/a
    		 -3.43

    Interest Coverage

    n/a
    		 -6.06

    Financial Efficiency

    Return on Equity is -3290.03% and Return on Invested Capital is -131.94%.

    Return on Equity

    n/a
    		 -3290.03%

    Return on Assets

    n/a
    		 -142.37%

    Return on Invested Capital

    n/a
    		 -131.94%

    Revenue Per Employee

    n/a
    		 $1,034,026.75

    Profits Per Employee

    n/a
    		 $-2,230,446.75

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0.66

    Inventory Turnover

    n/a
    		 5.86K

    Taxes

    Income Tax

    n/a
    		 5.34M

    Effective Tax Rate

    n/a
    		 -38.89%

    Stock Price Statistics

    The stock price has increased by -57% in the last 52 weeks. The beta is 2.17, so TRxADE HEALTH's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.17

    52-Week Price Change

    n/a
    		 -57%

    50-Day Moving Average

    n/a
    		 7.29

    200-Day Moving Average

    n/a
    		 8.98

    Relative Strength Index (RSI)

    n/a
    		 42.89

    Average Volume (20 Days)

    n/a
    		 61,782

    Income Statement

    In the last 12 months, TRxADE HEALTH had revenue of 8.27M and earned -17.84M in profits. Earnings per share was -23.35.

    Revenue

    n/a
    		 8.27M

    Gross Profit

    n/a
    		 2.6M

    Operating Income

    n/a
    		 -7.26M

    Net Income

    n/a
    		 -17.84M

    EBITDA

    n/a
    		 -13.72M

    EBIT

    n/a
    		 -12.52M

    Earnings Per Share (EPS)

    n/a
    		 -23.35
    Full Income Statement

    Balance Sheet

    The company has 151.91K in cash and 7.1M in debt, giving a net cash position of -6.95M.

    Cash & Cash Equivalents

    n/a
    		 151.91K

    Total Debt

    n/a
    		 7.1M

    Net Cash

    n/a
    		 -6.95M

    Retained Earnings

    n/a
    		 -33.25M

    Total Assets

    n/a
    		 14.85M

    Working Capital

    n/a
    		 9.17M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -2.07M and capital expenditures 0, giving a free cash flow of -2.07M.

    Operating Cash Flow

    n/a
    		 -2.07M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -2.07M

    FCF Per Share

    n/a
    		 -2.71
    Full Cash Flow Statement

    Margins

    Gross margin is 31.41%, with operating and profit margins of -87.8% and -215.7%.

    Gross Margin

    n/a
    		 31.41%

    Operating Margin

    n/a
    		 -87.8%

    Pretax Margin

    n/a
    		 -165.86%

    Profit Margin

    n/a
    		 -215.7%

    EBITDA Margin

    n/a
    		 -165.86%

    EBIT Margin

    n/a
    		 -87.8%

    FCF Margin

    n/a
    		 -25.07%

    Dividends & Yields

    MEDS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -449.11%

    FCF Yield

    n/a
    		 -52.19%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for MEDS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 19.31

    Graham Upside

    n/a
    		 154.41%

    Stock Splits

    The last stock split was on Jun 22, 2023. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Jun 22, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -1.93

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist